CCL19 and tuberculosis: For example, Wen et al. used WGCNA to preliminarily screen protein biomarkers, and the results were then combined with enzyme-linked immunosorbent assay results to verify CCL19, C1Qb, CCL5, and HLA-DMB as potentially effective biomarkers for TB diagnosis (Wen et al., 2022).